Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGylated recombinant human erythropoietin (RD01) in maintenance hemodialysis patients with chronic renal anemia
CTR20192157Phase 2Completed
- Sponsor
- Shenzhen Saibaoer Biopharmaceutical
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegerthropoietin in anemia of renal disease, sponsored by Shenzhen Saibaoer Biopharmaceutical. Started Feb 2020; status: completed.
02
Drugs
pegerthropoietin
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on CTR20192157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192157.